HealthSpan Lab
Why do so many groundbreaking health tech innovations struggle to reach the market—and the patients who need them most? And just as importantly: what kind of healthcare future lies ahead of us? To close out Season 2 of The HealthSpan Lab, I invited Romy Benninga, MSc, BCMAS, to help unpack the complex journey from scientific discovery to real-world impact—and explore the innovations shaping the future of care. Romy brings a rare 360° perspective, with hands-on experience in R&D, Medical Affairs, and business development across Switzerland, the UK, EU, and the US. In this episode, we dive into: * Why academic breakthroughs rarely become commercial products * What makes medtech and digital health particularly hard to scale * How to navigate regulatory, commercialization, and market hurdles * The strengths and differences between the US and EU approaches to innovation * A vision for more holistic and integrated patient care Whether you're a founder, clinician, investor, or simply curious about the future of healthcare, this episode is packed with practical insights into what it really takes to bring a health innovation to life.
12 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de HealthSpan Lab!